Alex DTx Platform

The smarter way to launch Digital Therapeutics.

We provide the platform that enables our partners to effectively and reliably launch new digital therapeutics (DTx) by leveraging existing insights, modules, processes and data.


Discover our Platform
Our Digital Therapeutics

Evidence-based digital interventions that deliver novel and personalized care

Digital Therapeutics (DTx) are evidence-based therapeutic interventions delivered as mobile software applications. They undergo rigorous clinical and regulatory review, ensuring the same high standards of efficacy and safety as with traditional drugs. A DTx can be prescribed by a physician alongside a drug or therapy or as a stand-alone treatment.

Learn more about DTx
VP04

Prescription DTx to increase quality of life for IPF patients.

The comprehensive DTx will provide treatment for currently under treated symptoms associated with IPF such as depression and anxiety, improving patient's quality of life.

Alex – Quit Smoking

The all-inclusive digital quit smoking coach.

Currently available for download in over 150 countries globally through the Apple App Store and Google Play.

Go to alexquitsmoking.com
AT04

Autonomous CBT treament targeting obesity.

Are you our partner in developing and commercializing our CBT obesity treatment built on the Alex DTx Platform? Reach out to learn more.

Get in touch
AT05

Depression and anxiety treatment for patients diagnosed with breast cancer.

Are you our partner in developing and commercializing our CBT breast cancer treatment built on the Alex DTx Platform? Reach out to learn more.

Get in touch

Empowering patients globally

With a patient-centric mentality, we are driven by our goal of delivering targeted personalized care. Our novel DTx treatments are developed in collaboration with patient groups and deliver targeted, personalized care to patients with overlooked symptoms.

More about us
Friends & Partners

Looking for the Alex – Quit Smoking app? Go to alexquitsmoking.com